Samsung Advanced Institute of Technology

Samsung Advanced Institute of Technology (SAIT) is the central research and development organization for the Samsung Group, dedicated to discovering and developing breakthrough technologies. In the healthcare and life sciences domain, SAIT focuses on innovative biopharmaceuticals, including bio-betters and next-generation antibody therapies, as well as advanced medical imaging and diagnostic devices. The institute integrates Samsung's core strengths in artificial intelligence, nanotechnology, and semiconductor physics to accelerate drug discovery and personalized medicine. While SAIT conducts early-stage research and proof-of-concept studies, its successful programs are typically transitioned to Samsung Bioepis or Samsung Biologics for late-stage development and manufacturing.